These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30106649)

  • 1. Real-World Data Analytics Fit for Regulatory Decision-Making.
    Schneeweiss S; Glynn RJ
    Am J Law Med; 2018 May; 44(2-3):197-217. PubMed ID: 30106649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real World Data in Adaptive Biomedical Innovation: A Framework for Generating Evidence Fit for Decision-Making.
    Schneeweiss S; Eichler HG; Garcia-Altes A; Chinn C; Eggimann AV; Garner S; Goettsch W; Lim R; Löbker W; Martin D; Müller T; Park BJ; Platt R; Priddy S; Ruhl M; Spooner A; Vannieuwenhuyse B; Willke RJ
    Clin Pharmacol Ther; 2016 Dec; 100(6):633-646. PubMed ID: 27627027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-World Evidence in the Real World: Beyond the FDA.
    Krause JH; Saver RS
    Am J Law Med; 2018 May; 44(2-3):161-179. PubMed ID: 30106647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practice-Based Research Networks and the Mandate for Real-World Evidence.
    Hall-Lipsy E; Barraza L; Robertson C
    Am J Law Med; 2018 May; 44(2-3):219-236. PubMed ID: 30106651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the Use of Nonrandomized Real-World Data Analyses for Regulatory Decision Making.
    Franklin JM; Glynn RJ; Martin D; Schneeweiss S
    Clin Pharmacol Ther; 2019 Apr; 105(4):867-877. PubMed ID: 30636285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DECISION-MAKING ALIGNED WITH RAPID-CYCLE EVALUATION IN HEALTH CARE.
    Schneeweiss S; Shrank WH; Ruhl M; Maclure M
    Int J Technol Assess Health Care; 2015 Jan; 31(4):214-22. PubMed ID: 26585440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial designs using real-world data: The changing landscape of the regulatory approval process.
    Baumfeld Andre E; Reynolds R; Caubel P; Azoulay L; Dreyer NA
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1201-1212. PubMed ID: 31823482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-World Evidence Should Be Used in Regulatory Decisions About New Pharmaceutical and Medical Device Products for Diabetes.
    Klonoff DC; Gutierrez A; Fleming A; Kerr D
    J Diabetes Sci Technol; 2019 Nov; 13(6):995-1000. PubMed ID: 30943790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When and How Can Real World Data Analyses Substitute for Randomized Controlled Trials?
    Franklin JM; Schneeweiss S
    Clin Pharmacol Ther; 2017 Dec; 102(6):924-933. PubMed ID: 28836267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Real-world Data for New Drug Applications and Line Extensions.
    Bolislis WR; Fay M; Kühler TC
    Clin Ther; 2020 May; 42(5):926-938. PubMed ID: 32340916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Building reliable evidence from real-world data: Needs, methods, cautiousness and recommendations.
    Corrao G; Cantarutti A
    Pulm Pharmacol Ther; 2018 Dec; 53():61-67. PubMed ID: 30253238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies.
    Makady A; Ham RT; de Boer A; Hillege H; Klungel O; Goettsch W;
    Value Health; 2017 Apr; 20(4):520-532. PubMed ID: 28407993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health Insurance Portability Accountability Act (HIPAA) regulations: effect on medical record research.
    O'Herrin JK; Fost N; Kudsk KA
    Ann Surg; 2004 Jun; 239(6):772-6; discussion 776-8. PubMed ID: 15166956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.
    Mullins CD; Sanchez RJ
    J Manag Care Pharm; 2011; 17(9 Suppl A):S03-4. PubMed ID: 22074667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncertainty in assessing value of oncology treatments.
    Mullins CD; Montgomery R; Tunis S
    Oncologist; 2010; 15 Suppl 1():58-64. PubMed ID: 20237219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.